시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 세포치료기술 시장 - 규모, 점유율, 성장 분석 : 유형별, 프로세스별, 세포 유형별, 최종사용자별, 지역별 산업 예측(2024-2031년)
Cell Therapy Technologies Market Size, Share, Growth Analysis, By Type, By Process, By Cell Type, By End User, By Region - Industry Forecast 2024-2031
상품코드 : 1619047
리서치사 : SkyQuest
발행일 : 2024년 12월
페이지 정보 : 영문 201 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,679,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,983,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,287,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세포치료기술 세계 시장 규모는 2022년 39억 달러로 평가되었고, 2023년 44억 3,000만 달러에서 2031년에는 121억 9,000만 달러로 성장해 예측기간(2024-2031년) CAGR은 13.50%로 성장할 전망입니다.

세포치료시장은 임상연구에 대한 자금 증가와 실용적인 생산가이드라인의 확립에 힘입어 큰 성장을 이루고 있습니다. 양질의 연구는 치료 세포 개발의 진전을 촉진하고 현저한 시장 점유율 확대를 가져오고 있습니다. 임상시험 증가는 민간 및 정부 자금 제공 기관에 의해 크게 지원되고 있으며, 유럽 프로젝트는 EU 보조금에 의해 자주 지원됩니다. 예를 들어, Achilles Therapeutics는 맞춤형 의료를 더욱 발전시키기 위해 2022년 7월에 420만 달러의 Horizon Europe 상을 수상했습니다. 또한 CRISPR/Cas9와 같은 유전자 편집 기술과 제조 자동화 등 세포 치료 기술의 진보가 세포 치료의 확장성과 질을 높이고 있습니다.

목차

소개

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

세포치료기술 시장 규모 : 제품별 및 CAGR(2024-2031년)

세포치료기술 시장 규모 : 프로세스별 및 CAGR(2024-2031년)

세포치료기술 시장 규모 : 세포 유형별 및 CAGR(2024-2031년)

세포치료기술 시장 규모 : 최종 사용자별 및 CAGR(2024-2031년)

세포치료기술 시장 규모 및 CAGR(2024-2031년)

경쟁 정보

주요 기업 프로파일

결론과 권장사항

JHS
영문 목차

영문목차

Global Cell Therapy Technologies Market size was valued at USD 3.9 billion in 2022 and is poised to grow from USD 4.43 billion in 2023 to USD 12.19 billion by 2031, growing at a CAGR of 13.50% during the forecast period (2024-2031).

The cell therapy market is experiencing significant growth fueled by increased funding for clinical research and the establishment of practical guidelines for production. Robust quality research is driving the advancement of therapeutic cell development, resulting in a notable market share expansion. The rise in clinical trials is largely supported by both private and government funding agencies, with European projects frequently backed by EU grants; for instance, Achilles Therapeutics secured a $4.2 million Horizon Europe award in July 2022 to further personalized medicine. Additionally, advancements in cell therapy techniques, including gene editing technologies like CRISPR/Cas9 and automation in manufacturing, are enhancing the scalability and quality of cell therapies, while regulatory approvals remain a decisive factor in market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Therapy Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Therapy Technologies Market Segmental Analysis

Global Cell Therapy Technologies Market is segmented by Type, Process, Cell Type, End User, and region. Based on Type, the market is segmented into Media, sera, and reagents, Cell engineering products, Cell culture vessels, Cell therapy equipment, Systems & software, and Other products. Based on Process, the market is segmented into Cell Processing, Cell preservation, distribution, and handling, and Process monitoring & quality control. Based on Cell Type, the market is segmented into T cells, Stem cells, and Other cells. Based on End User, the market is segmented into Biopharmaceutical & biotechnology companies, CROs & CMOs, and Research institutes & cell banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Therapy Technologies Market

One of the key drivers fueling the expansion of the global cell therapy technologies market is the continuous emergence of innovative therapies. This growth is largely attributable to the frequent introduction of advanced technologies aimed at facilitating state-of-the-art treatments. Notably, the deployment of proprietary cell lines is recognized as an effective method for achieving a substantial target population for specific products. A prime example of this is Immunicum's utilization of Chimeric Antigen Receptor T cell (CAR-T) expansion, along with dendritic cell neoantigen presentation techniques and T-cell priming strategies, all of which significantly enhance the development of their immuno-oncology portfolio.

Restraints in the Global Cell Therapy Technologies Market

The Global Cell Therapy Technologies market faces significant challenges due to a shortage of skilled labor. Despite notable technological progress and innovations in recent years, there remains a dearth of qualified personnel capable of operating sophisticated instruments like flow cytometers and spectrophotometers. These advanced tools produce substantial volumes of data, necessitating a high level of expertise for effective analysis and interpretation. This gap in skilled workforce not only hampers operational efficiency but also poses a barrier to the overall growth and advancement of the cell therapy sector, potentially limiting its ability to leverage technological advancements fully.

Market Trends of the Global Cell Therapy Technologies Market

The Global Cell Therapy Technologies market is experiencing significant growth, driven by the increasing demand for advanced analytical tools that enhance quality control and improvement. Innovative diagnostics, imaging technologies, and robust data analytics facilitate the streamlined monitoring and characterization of cellular materials, ensuring enhanced efficacy and safety profiles. The development of new biomaterials and scaffolds for improved cell delivery and engraftment is garnering heightened interest, offering benefits like better biocompatibility and controlled release kinetics. Moreover, intensified collaboration between research institutions is fostering innovation, aiding the rapid translation of cell therapy technologies from laboratory research to clinical application, positioning this sector for continued expansion.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Cell Therapy Technologies Market Size by Product & CAGR (2024-2031)

Global Cell Therapy Technologies Market Size by Process & CAGR (2024-2031)

Global Cell Therapy Technologies Market Size by Cell Type & CAGR (2024-2031)

Global Cell Therapy Technologies Market Size by End User & CAGR (2024-2031)

Global Cell Therapy Technologies Market Size & CAGR (2024-2031)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendation

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기